Healthcare -
Biotechnology - NASDAQ - US
$ 1.25
1.63 %
$ 39.2 M
Market Cap
-0.58
P/E
ACRV - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities ACRV - Acrivon Therapeutics, Inc. Common Stock
121 M
LAST VALUE
9.08%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR